Challenges and perspective in the fight against tuberculosis in the Democratic Republic of Congo
Aymar Akilimali(Roslin Institute), Olivier Nyakio(Faculty (United Kingdom)), Leonard Sironge(Université Officielle de Bukavu), Fabrice Kibukila(Université Officielle de Bukavu), Jones Onesime(Université libre des Pays des Grands Lacs), Hugues Cakwira(Green Circle), Christian Ahadi Irenge(Université Officielle de Bukavu), Styves Banga(Green Circle), Chrispin Biamba(University of Goma), Malik Olatunde Oduoye(Ahmadu Bello University), Ibad Ur Rehman(Shifa Tameer-e-Millat University), Michel K. Mirindi
Cited by 0
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review
|Health Science Reports|2024|62
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29